Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

[Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections].

Koss MJ, Bolz M, Augustin AJ, Koch F, Szurman P, Stanzel B, Fauser S, Mennel S, Vossmerbäumer U, de Smet MD, Höhn F, Küchle M, Lorenz B, Lüke M, Lytvynchuk L, Meyer CH, Paul C, Rodrigues EB, Schrage N, Zehnder C.

Klin Monbl Augenheilkd. 2019 Nov 26. doi: 10.1055/a-0972-9747. [Epub ahead of print] German. No abstract available.

PMID:
31770791
2.

First-line treatment algorithm and guidelines in center-involving diabetic macular edema.

Kodjikian L, Bellocq D, Bandello F, Loewenstein A, Chakravarthy U, Koh A, Augustin A, de Smet MD, Chhablani J, Tufail A, García-Layana A, Sudhalkar A, Mathis T.

Eur J Ophthalmol. 2019 Nov;29(6):573-584. doi: 10.1177/1120672119857511. Epub 2019 Jun 26.

PMID:
31238719
3.

Re: van Bree et al.: Straylight as an Indicator for Cataract Extraction in Patients with Retinal Dystrophy.

de Smet MD, Castilla-Marti M.

Ophthalmol Retina. 2018 Aug;2(8):e9. doi: 10.1016/j.oret.2018.03.010. Epub 2018 Apr 30. No abstract available.

PMID:
31047544
4.

Human/robotic interaction: vision limits performance in simulated vitreoretinal surgery.

de Smet MD, de Jonge N, Iannetta D, Faridpooya K, van Oosterhout E, Naus G, Meenink TCM, Mura M, Beelen MJ.

Acta Ophthalmol. 2019 Nov;97(7):672-678. doi: 10.1111/aos.14003. Epub 2018 Dec 27.

PMID:
30588753
5.

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):: The Phase 2 SATURN Study.

Heissigerová J, Callanan D, de Smet MD, Srivastava SK, Karkanová M, Garcia-Garcia O, Kadayifcilar S, Ozyazgan Y, Vitti R, Erickson K, Athanikar A, Chu K, Saroj N, Sundaram PA, Varona R, Corp-Dit-Genti V, Buggage R, Cheng Y, Soo Y, Nguyen QD.

Ophthalmology. 2019 Mar;126(3):428-437. doi: 10.1016/j.ophtha.2018.09.044. Epub 2018 Oct 11.

PMID:
30316888
6.

First-in-human study of the safety and viability of intraocular robotic surgery.

Edwards TL, Xue K, Meenink HCM, Beelen MJ, Naus GJL, Simunovic MP, Latasiewicz M, Farmery AD, de Smet MD, MacLaren RE.

Nat Biomed Eng. 2018 Jun 18;2:649-656. doi: 10.1038/s41551-018-0248-4.

7.

Robotic-assisted surgery in ophthalmology.

de Smet MD, Naus GJL, Faridpooya K, Mura M.

Curr Opin Ophthalmol. 2018 May;29(3):248-253. doi: 10.1097/ICU.0000000000000476. Review.

PMID:
29553953
8.

A Subretinal Cell Delivery Method via Suprachoroidal Access in Minipigs: Safety and Surgical Outcomes.

de Smet MD, Lynch JL, Dejneka NS, Keane M, Khan IJ.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):311-320. doi: 10.1167/iovs.17-22233.

PMID:
29346488
9.

Toward the Art of Robotic-assisted Vitreoretinal Surgery.

Molaei A, Abedloo E, de Smet MD, Safi S, Khorshidifar M, Ahmadieh H, Khosravi MA, Daftarian N.

J Ophthalmic Vis Res. 2017 Apr-Jun;12(2):212-218. doi: 10.4103/jovr.jovr_63_17.

10.

Insights into the Physiopathology of Inflammatory Macular Edema.

de Smet MD.

Dev Ophthalmol. 2017;58:168-177. doi: 10.1159/000455279. Epub 2017 Mar 28. Review.

PMID:
28351051
11.

Release of experimental retinal vein occlusions by direct intraluminal injection of ocriplasmin.

de Smet MD, Stassen JM, Meenink TC, Janssens T, Vanheukelom V, Naus GJ, Beelen MJ, Jonckx B.

Br J Ophthalmol. 2016 Dec;100(12):1742-1746. doi: 10.1136/bjophthalmol-2016-309190. Epub 2016 Sep 28.

12.

Robotic Assisted Cannulation of Occluded Retinal Veins.

de Smet MD, Meenink TC, Janssens T, Vanheukelom V, Naus GJ, Beelen MJ, Meers C, Jonckx B, Stassen JM.

PLoS One. 2016 Sep 27;11(9):e0162037. doi: 10.1371/journal.pone.0162037. eCollection 2016.

13.

Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Stam AH, Kothari PH, Shaikh A, Gschwendter A, Jen JC, Hodgkinson S, Hardy TA, Hayes M, Kempster PA, Kotschet KE, Bajema IM, van Duinen SG, Maat-Schieman MLC, de Jong PTVM, de Smet MD, de Wolff-Rouendaal D, Dijkman G, Pelzer N, Kolar GR, Schmidt RE, Lacey J, Joseph D, Fintak DR, Grand MG, Brunt EM, Liapis H, Hajj-Ali RA, Kruit MC, van Buchem MA, Dichgans M, Frants RR, van den Maagdenberg AMJM, Haan J, Baloh RW, Atkinson JP, Terwindt GM, Ferrari MD.

Brain. 2016 Nov 1;139(11):2909-2922. doi: 10.1093/brain/aww217. No abstract available.

14.

T-shaped macular buckling combined with 25G pars plana vitrectomy for macular hole, macular schisis, and macular detachment in highly myopic eyes.

Mura M, Iannetta D, Buschini E, de Smet MD.

Br J Ophthalmol. 2017 Mar;101(3):383-388. doi: 10.1136/bjophthalmol-2015-308124. Epub 2016 May 27.

PMID:
27234876
15.

Use of a new intra-ocular spectral domain optical coherence tomography in vitreoretinal surgery.

Mura M, Iannetta D, Nasini F, Barca F, Peiretti E, Engelbrecht L, de Smet MD, Verbraak F.

Acta Ophthalmol. 2016 May;94(3):246-52. doi: 10.1111/aos.12961. Epub 2016 Feb 4.

16.

Vitreous Biopsy Under Air.

Mura M, Buschini E, Iannetta D, de Smet MD.

Retina. 2016 Apr;36(4):838-9. doi: 10.1097/IAE.0000000000000939. No abstract available.

PMID:
26713840
17.

Sustained-release Corticosteroids for Uveitis.

Cunningham ET Jr, de Smet MD, Yeh S, Albini TA, Zierhut M.

Ocul Immunol Inflamm. 2015;23(6):421-4. doi: 10.3109/09273948.2015.1114778. No abstract available.

PMID:
26652837
18.

Incorrect use and presentation of the RADNER Reading Charts: comment on measurement of reading speed with standardized texts: a comparison of single sentences and paragraphs, by Altpeter E, Marx T, Nguyen N, Naumann A, Trauzettel-Klosinski S.

Radner W, Maaijwee K, de Smet MD, Benesch T.

Graefes Arch Clin Exp Ophthalmol. 2016 Apr;254(4):813-5. doi: 10.1007/s00417-015-3183-z. Epub 2015 Oct 13. No abstract available.

19.

Effect of vitreous opacities on straylight measurements.

Castilla-Marti M, van den Berg TJ, de Smet MD.

Retina. 2015 Jun;35(6):1240-6. doi: 10.1097/IAE.0000000000000456.

PMID:
25650709
20.

Surgical management of severe complications arising from uveitis in juvenile idiopathic arthritis.

Langner-Wegscheider BJ, de Smet MD.

Ophthalmologica. 2014;232(3):179-86. doi: 10.1159/000365230. Epub 2014 Oct 18.

PMID:
25342480
21.

Treatment of macular edema secondary to retinal vein occlusion.

Amstutz C, Becht-Toenz C, de Smet MD, Garweg J, Haueter I, Josifova T, Stürmer J.

Eur J Ophthalmol. 2014 Jul-Aug;24(4):641-2. doi: 10.5301/ejo.5000476. Epub 2014 Apr 24. No abstract available.

PMID:
24760605
22.

Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion.

Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G, Parravano MC, Udaondo P, Moisseiev E, Soubrane G, Yatziv Y, Loewenstein A.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):1-9. doi: 10.5301/ejo.5000376. Epub 2013 Oct 14.

PMID:
24249150
23.

Ocriplasmin for diabetic retinopathy.

de Smet MD, Castilla M.

Expert Opin Biol Ther. 2013 Dec;13(12):1741-7. doi: 10.1517/14712598.2013.853737. Review.

PMID:
24206115
24.

Air as tamponade for retinal detachments.

Mateo-Montoya A, de Smet MD.

Eur J Ophthalmol. 2014 Mar-Apr;24(2):242-6. doi: 10.5301/ejo.5000373. Epub 2013 Sep 23.

PMID:
24170524
25.

The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole.

Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P.

Ophthalmology. 2013 Dec;120(12):2611-2619. doi: 10.1016/j.ophtha.2013.07.042. Epub 2013 Sep 17.

PMID:
24053995
26.

The vitreous, the retinal interface in ocular health and disease.

de Smet MD, Gad Elkareem AM, Zwinderman AH.

Ophthalmologica. 2013;230(4):165-78. doi: 10.1159/000353447. Epub 2013 Aug 24. Review.

27.

Image diagnostic agreement in uveitis: a picture is worth a thousand words but is it sufficient to diagnose?

de Smet MD.

Can J Ophthalmol. 2013 Aug;48(4):223-5. doi: 10.1016/j.jcjo.2013.06.002. No abstract available.

PMID:
23931457
28.

Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis.

Julian K, Langner-Wegscheider BJ, Haas A, De Smet MD.

Retina. 2013 Oct;33(9):1943-8. doi: 10.1097/IAE.0b013e318285cdbe.

PMID:
23584698
29.

Intravitreal methotrexate for the treatment of choroidal neovascularization in multifocal choroiditis.

Mateo-Montoya A, Baglivo E, de Smet MD.

Eye (Lond). 2013 Feb;27(2):277-8. doi: 10.1038/eye.2012.262. Epub 2012 Dec 7. No abstract available.

30.

Pharmacokinetics of ocriplasmin in vitreous.

de Smet MD, Jonckx B, Vanhove M, van Calster J, Stalmans P, Stassen JM.

Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8208-13. doi: 10.1167/iovs.12-10148.

PMID:
23150619
31.

Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.

Gad Elkareem AM, de Smet MD.

Acta Ophthalmol. 2014 Feb;92(1):47-50. doi: 10.1111/j.1755-3768.2012.02568.x. Epub 2012 Oct 1.

32.

Corticosteroid intravitreal implants.

de Smet MD.

Dev Ophthalmol. 2012;51:122-33. doi: 10.1159/000336330. Epub 2012 Apr 17. Review.

PMID:
22517210
33.

Mechanism of inactivation of ocriplasmin in porcine vitreous.

Aerts F, Noppen B, Fonteyn L, Derua R, Waelkens E, de Smet MD, Vanhove M.

Biophys Chem. 2012 May;165-166:30-8. doi: 10.1016/j.bpc.2012.03.002. Epub 2012 Mar 8.

34.

Surgery for floaters.

Mura M, Engelbrecht LA, de Smet MD, Papadaki TG, van den Berg TJ, Tan HS.

Ophthalmology. 2011 Sep;118(9):1894-1894.e1. doi: 10.1016/j.ophtha.2011.05.020. No abstract available.

PMID:
21889665
35.

Understanding uveitis: the impact of research on visual outcomes.

de Smet MD, Taylor SR, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, Zierhut M, Barisani-Asenbauer T, LeHoang P, Lightman S.

Prog Retin Eye Res. 2011 Nov;30(6):452-70. doi: 10.1016/j.preteyeres.2011.06.005. Epub 2011 Jul 22. Review.

PMID:
21807112
36.

The additional value of blood culture bottles in the diagnosis of endophthalmitis.

Tan HS, Ghyczy-Carlborg EA, Spanjaard L, de Smet MD.

Eye (Lond). 2011 Aug;25(8):1069-73. doi: 10.1038/eye.2011.142. Epub 2011 Jun 17.

37.

The role of steroids in the management of uveitic macular edema.

de Smet MD, Julian K.

Eur J Ophthalmol. 2011;21 Suppl 6:S51-5. doi: 10.5301/EJO.2010.6056. Review.

PMID:
23264329
38.

Characterization of a stabilized form of microplasmin for the induction of posterior vitreous detachment.

Gad Elkareem AM, Willekens B, Vanhove M, Noppen B, Stassen JM, de Smet MD.

Curr Eye Res. 2010 Oct;35(10):909-15. doi: 10.3109/02713683.2010.494819.

PMID:
20858112
39.

Cystoid macular edema in uveitis.

de Smet MD, Okada AA.

Dev Ophthalmol. 2010;47:136-147. doi: 10.1159/000320077. Epub 2010 Aug 10. Review.

PMID:
20703047
40.

Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial).

Stalmans P, Delaey C, de Smet MD, van Dijkman E, Pakola S.

Retina. 2010 Jul-Aug;30(7):1122-7. doi: 10.1097/IAE.0b013e3181e0970a.

PMID:
20616687
41.

Enhanced internal search for iatrogenic retinal breaks in 20-gauge macular surgery.

Tan HS, Lesnik Oberstein SY, Mura M, de Smet MD.

Br J Ophthalmol. 2010 Nov;94(11):1490-2. doi: 10.1136/bjo.2009.172791. Epub 2010 May 21.

PMID:
20494906
42.

Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis.

Langner-Wegscheider BJ, ten Dam-van Loon N, Mura M, Faridpooya K, de Smet MD.

Can J Ophthalmol. 2010 Apr;45(2):157-60. doi: 10.3129/i09-262.

PMID:
20379302
43.

Differential vitreous dye diffusion following microplasmin or plasmin pre-treatment.

Gad Elkareem AM, Willikens B, Stassen JM, de Smet MD.

Curr Eye Res. 2010 Mar;35(3):235-41. doi: 10.3109/02713680903484259.

PMID:
20373883
44.

Bilateral talc maculopathy and fibrovascular proliferation in a drug abuser.

Ruys J, de Smet MD, Van de Sompel W.

Retin Cases Brief Rep. 2010 Spring;4(2):123-4. doi: 10.1097/ICB.0b013e31819bfa57.

PMID:
25390381
45.

Primary retinectomy in proliferative vitreoretinopathy.

Tan HS, Mura M, Oberstein SY, de Smet MD.

Am J Ophthalmol. 2010 Mar;149(3):447-52. doi: 10.1016/j.ajo.2009.10.017.

PMID:
20172071
46.

Use of heavy Trypan blue in macular hole surgery.

Lesnik Oberstein SY, de Smet MD.

Eye (Lond). 2010 Jul;24(7):1177-81. doi: 10.1038/eye.2010.3. Epub 2010 Feb 12.

PMID:
20150921
47.

Use of 25-gauge vitrectomy in the management of primary rhegmatogenous retinal detachment.

Mura M, Tan SH, De Smet MD.

Retina. 2009 Oct;29(9):1299-1304. doi: 10.1097/IAE.0b013e3181aa0f5f.

PMID:
19629017
48.

Bilateral granulomatous uveitis as a side effect of topical brimonidine: two case reports.

Hondeghem K, Augustinus B, De Smet MD.

Bull Soc Belge Ophtalmol. 2009;(311):51-2. No abstract available.

PMID:
19621555
49.

Iatrogenic retinal breaks in 25-gauge macular surgery.

Tan HS, Mura M, de Smet MD.

Am J Ophthalmol. 2009 Sep;148(3):427-30. doi: 10.1016/j.ajo.2009.04.002. Epub 2009 May 24.

PMID:
19477712
50.

Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.

de Smet MD, Gandorfer A, Stalmans P, Veckeneer M, Feron E, Pakola S, Kampik A.

Ophthalmology. 2009 Jul;116(7):1349-55, 1355.e1-2. doi: 10.1016/j.ophtha.2009.03.051. Epub 2009 May 17.

PMID:
19447497

Supplemental Content

Support Center